Transcriptomics Signature of Anti Vaccinia Memory B Cells

Transcriptomics Signature of Anti Vaccinia Memory B Cells in Healthy Individuals at a Short Time After Vaccination

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02556489

Enrollment

Registered

2015-09-22

Start date

2015-11-03

Completion date

2018-02-05

Last updated

2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

immunological memory

Brief summary

Analyse the transcriptomic signature of anti vaccinia memory B cells at a short time after vaccination as compared to the signature already established in long-lived memory B cells.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to 50 Years

Healthy volunteers

Yes

Inclusion criteria

* Healthy donors vaccinated against smallpox

Exclusion criteria

* none

Design outcomes

Primary

Measure	Time frame	Description
Analysis of B memory cells	12 months	B-memory cells will be analysed to determine, on an individual basis, whether they express the long-lived signature

Countries

France

Outcome results